This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Welcome to Reed Smith's viewpoints — timely commentary from our lawyers on topics relevant to your business and wider industry. Browse to see the latest news and subscribe to receive updates on topics that matter to you, directly to your mailbox.
| less than a minute read

Cannabis within the broader deal market

Friends, a curious bit of perspective.

Global M&A activity over the first half of 2020 is down by 32% in volume and 53% in value year-over-year, not surprisingly due to COVID-19. (link) In comparison, although Cannabis valuations started to fall in the second quarter of 2019, and cannabis deal activity started to slow well before the pandemic hit, activity in the industry has similarly slowed down markedly in 2020.

Yet, while US retail sales generally have struggled (although they’ve been recently picking up), US cannabis businesses have only seen demand grow dramatically throughout the year. (link)

This hearkens back to a point about the industry I made in March (link), namely that, although the product is proving itself to be recession-proof, demand alone may not allow it to fully escape the event horizon of the global economic downtown.



Latest Insights